These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3131488)

  • 21. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta].
    Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
    Onishi T; Machida T; Masuda F; Iizuka N; Nakauchi K; Furuta N; Shirakawa H
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1571-8. PubMed ID: 2121869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of natural human tumor necrosis factor-alpha in combination with natural human interferon-alpha or -gamma on human cancer cells.
    Shiiki S; Fuchimoto S; Orita K
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):345-51. PubMed ID: 3141998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation-inducing and cytotoxic effects of tumor necrosis factor and interferon-gamma in myeloblastic ML-1 cells.
    Craig RW; Buchan HL
    J Cell Physiol; 1989 Oct; 141(1):46-52. PubMed ID: 2506196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.
    Nishihara K; Barth RF; Wilkie N; Lang JC; Oda Y; Kikuchi H; Everson MP; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):113-24. PubMed ID: 7621259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
    Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
    J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M; Jewett A
    Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmented procoagulant activity in cancer patients, treated with recombinant interferon-gamma in addition to recombinant tumor necrosis factor-alpha and melphalan.
    Mulder AB; Zwaveling JH; Smid WM; Maring JK; van Ginkel RJ; Girbes AR; Schraffordt Koops H; van der Meer J
    Thromb Haemost; 1996 Dec; 76(6):897-901. PubMed ID: 8972008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-cervix-cancer effect of the co-immobilization of tumor necrosis factor-alpha and interferon-gamma].
    Guan Y; He L; Cai S; Zhou T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Dec; 23(6):1303-7. PubMed ID: 17228731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha.
    Buntinx M; Gielen E; Van Hummelen P; Raus J; Ameloot M; Steels P; Stinissen P
    J Neurosci Res; 2004 Jun; 76(6):846-61. PubMed ID: 15160396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD; Erickson KL
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis.
    Buntinx M; Moreels M; Vandenabeele F; Lambrichts I; Raus J; Steels P; Stinissen P; Ameloot M
    J Neurosci Res; 2004 Jun; 76(6):834-45. PubMed ID: 15160395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between cell kinetics and apoptotic effects in TNF-alpha and IFN-gamma-treated human tumour cell lines.
    Baisch H
    Eur Cytokine Netw; 2001; 12(4):604-13. PubMed ID: 11781187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic induction of polypeptides by tumor necrosis factor and interferon-gamma in cells sensitive or resistant to tumor necrosis factor: assessment by computer based analysis of two-dimensional gels using the PDQUEST system.
    Beresini MH; Sugarman BJ; Shepard HM; Epstein LB
    Electrophoresis; 1990 Mar; 11(3):232-41. PubMed ID: 2111772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
    Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes.
    Adamson GM; Billings RE
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):100-7. PubMed ID: 7682342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.